OTCPK:JLFN.F

Stock Analysis Report

Executive Summary

Japan Lifeline Co., Ltd., a medical device company, imports, develops, produces, distributes, and trades in cardiovascular related medical devices in Japan.

Snowflake

Fundamentals

Flawless balance sheet average dividend payer.

Share Price & News

How has Japan Lifeline's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

JLFN.F

0.008%

US Healthcare

-0.2%

US Market


1 Year Return

n/a

JLFN.F

-9.0%

US Healthcare

1.1%

US Market

No trading data on JLFN.F.

No trading data on JLFN.F.


Share holder returns

JLFN.FIndustryMarket
7 Day0%0.008%-0.2%
30 Day0%-0.8%2.5%
90 Day0%-1.5%1.6%
1 Yearn/a-7.6%-9.0%3.4%1.1%
3 Yearn/a29.6%24.4%45.2%35.8%
5 Yearn/a66.2%56.2%62.6%44.8%

Price Volatility Vs. Market

How volatile is Japan Lifeline's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Japan Lifeline undervalued based on future cash flows and its price relative to the stock market?

23%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Japan Lifeline's share price is below the future cash flow value, and at a moderate discount (> 20%).

Japan Lifeline's share price is below the future cash flow value, but not at a substantial discount (< 40%).


Price Based on Earnings

Japan Lifeline is good value based on earnings compared to the US Healthcare industry average.

Japan Lifeline is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Japan Lifeline is poor value based on expected growth next year.


Price Based on Value of Assets

Japan Lifeline is overvalued based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is Japan Lifeline expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

11.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Japan Lifeline's revenue is expected to grow by 11.5% yearly, however this is not considered high growth (20% yearly).

Japan Lifeline's earnings are expected to grow by 11.9% yearly, however this is not considered high growth (20% yearly).

Japan Lifeline's revenue growth is expected to exceed the United States of America market average.

Japan Lifeline's earnings growth is positive but not above the United States of America market average.

Japan Lifeline's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Japan Lifeline is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Japan Lifeline performed over the past 5 years?

48.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Japan Lifeline has delivered over 20% year on year earnings growth in the past 5 years.

Japan Lifeline's 1-year earnings growth is less than its 5-year average (9.5% vs 48.9%)

Japan Lifeline's earnings growth has not exceeded the US Healthcare industry average in the past year (9.5% vs 17.5%).


Return on Equity

Japan Lifeline has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Japan Lifeline used its assets more efficiently than the US Healthcare industry average last year based on Return on Assets.


Return on Capital Employed

Japan Lifeline has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Japan Lifeline's financial position?


Financial Position Analysis

Japan Lifeline is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Japan Lifeline's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Japan Lifeline's level of debt (21.6%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (44.8% vs 21.6% today).

Debt is well covered by operating cash flow (49.3%, greater than 20% of total debt).

Japan Lifeline earns more interest than it pays, coverage of interest payments is not a concern.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 3.7x debt.


Next Steps

Dividend

What is Japan Lifeline's current dividend yield, its reliability and sustainability?

1.67%

Expected Dividend Yield


Dividend Yield and Payments Analysis

Japan Lifeline's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.4%).

Japan Lifeline's dividend is below the markets top 25% of dividend payers in United States of America (3.61%).

Dividends per share have been stable in the past 10 years.

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are well covered by earnings (3.3x coverage).


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Japan Lifeline's salary, the management and board of directors tenure and is there insider trading?

7.8yrs

Average management tenure


CEO

Keisuke Suzuki (65yo)

0yrs

Tenure

0

Mr. Keisuke Suzuki has been the President of Japan Lifeline Co., Ltd. since June 2005 and serves as its Chief Executive Officer. Mr. Suzuki served as Vice President of Japan Lifeline Co., Ltd., since April ...


Management Age and Tenure

7.8yrs

Average Tenure

59.5yo

Average Age

The average tenure for the Japan Lifeline management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

7.7yrs

Average Tenure

59.5yo

Average Age

The tenure for the Japan Lifeline board of directors is about average.


Insider Trading

No 3 month insider trading information.


Ownership Breakdown


Management Team

  • Keisuke Suzuki (65yo)

    CEO, President & Representative Director

    • Tenure: 0yrs
  • Atsuhiro Suzuki (60yo)

    Senior EVP

    • Tenure: 13.7yrs
  • Takayuki Kuronuma (62yo)

    VP, GM of Operations Division & Director

    • Tenure: 9.7yrs
  • Shogo Takahashi (54yo)

    Executive VP

    • Tenure: 7.7yrs
  • Fumihiro Sasaki (61yo)

    Outside VP & External Director

    • Tenure: 6.7yrs
  • Kazuhiko Nogami (60yo)

    VP, GM of EP Business Division & Director

    • Tenure: 0yrs
  • Kenji Yamada (47yo)

    VP, GM of Administrative Division & Director

    • Tenure: 0yrs
  • Osamu Watanabe (59yo)

    VP, GM of CRM Business Division & Director

    • Tenure: 0yrs
  • Toru Takamiya (54yo)

    VP, GM of CV Business Division & Director

    • Tenure: 1.7yrs
  • Tadashi Idei (53yo)

    VP, GM of Pharmaceutical Division & Director

    • Tenure: 1.7yrs

Board Members

  • Keisuke Suzuki (65yo)

    CEO, President & Representative Director

    • Tenure: 0yrs
  • Atsuhiro Suzuki (60yo)

    Senior EVP

    • Tenure: 13.7yrs
  • Takayuki Kuronuma (62yo)

    VP, GM of Operations Division & Director

    • Tenure: 9.7yrs
  • Shogo Takahashi (54yo)

    Executive VP

    • Tenure: 7.7yrs
  • Fumihiro Sasaki (61yo)

    Outside VP & External Director

    • Tenure: 6.7yrs
  • Kazuhiko Nogami (60yo)

    VP, GM of EP Business Division & Director

    • Tenure: 0yrs
  • Kenji Yamada (47yo)

    VP, GM of Administrative Division & Director

    • Tenure: 0yrs
  • Osamu Watanabe (59yo)

    VP, GM of CRM Business Division & Director

    • Tenure: 0yrs
  • Toru Takamiya (54yo)

    VP, GM of CV Business Division & Director

    • Tenure: 1.7yrs
  • Tadashi Idei (53yo)

    VP, GM of Pharmaceutical Division & Director

    • Tenure: 1.7yrs

Company Information

Japan Lifeline Co., Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Japan Lifeline Co., Ltd.
  • Ticker: JLFN.F
  • Exchange: OTCPK
  • Founded: 1981
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: JP¥151.822b
  • Listing Market Cap: JP¥1.369b
  • Shares outstanding: 80.41m
  • Website: https://www.japanlifeline.com

Number of Employees


Location

  • Japan Lifeline Co., Ltd.
  • NYK Tennoz Building
  • 25th Floor
  • Tokyo
  • 140-0002
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
7575TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYDec 1997
JLFN.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDDec 1997
7575JASDAQ (TSE JASDAQ)YesCommon StockJPJPYDec 1997

Biography

Japan Lifeline Co., Ltd., a medical device company, imports, develops, produces, distributes, and trades in cardiovascular related medical devices in Japan. Its cardiac rhythm management products include c ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/02/28 01:47
End of Day Share Price2018/11/30 00:00
Earnings2018/12/31
Annual Earnings2018/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.